Potential Barriers of Access to the New CGRP Class

Dr. Amaal Starling shares insights on how to access the new class of migraine treatment

Wondering if the new class of migraine treatments are right for you? In a recent webinar, Dr. Amaal Starling shared potential accessibility issues with the new anti-CGRP treatments. Three new treatments, all released this year, are widely viewed as a major breakthrough in migraine prevention. Dr. Starling is a practicing neurologist and assistant professor of neurology at the Mayo Clinic. Find out more about who is right for these treatments in the video below.